J, H., M, A., F, T., R, B., S, V., & LG, C. (2026). Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis. Diabetes, obesity & metabolism, 28(8), 7058-7072. https://doi.org/10.1111/dom.70687
Παραπομπή σε μορφή Chicago (17η εκδ.)J, Hollinghurst, Augusto M, Tefos F, Bauer R, Vadapalle S, και Cardél LG. "Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis." Diabetes, Obesity & Metabolism 28, no. 8 (2026): 7058-7072. https://doi.org/10.1111/dom.70687.
Παραπομπή σε μορφή MLA (9th εκδ.)J, Hollinghurst, et al. "Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis." Diabetes, Obesity & Metabolism, vol. 28, no. 8, 2026, pp. 7058-7072, https://doi.org/10.1111/dom.70687.